HTTP://WWW.ABINGWORTH.COM LONDON, X0 Investment Advisor How do I update this listing?

Subscription Required

WhaleScore 2.0 ?


S&P 500
WhaleScore ?

Subscription Required

WhaleScore ?

Abingworth LLP is based out of London. Abingworth LLP is a registered investment advisory firm with discretionary assets under management (AUM) of $0 (Form ADV from 2015-02-25). Their last reported 13F filing for Q1 2021 included $289,551,000 in managed 13F securities and a top 10 holdings concentration of 94.95%. Abingworth LLP's largest holding is Vaxcyte, Inc. with shares held of 4,168,718. Abingworth LLP has met the qualifications for inclusion in our WhaleScore system. Whalewisdom has at least 43 13F filings, 42 13D filings, 21 13G filings, and 18 Form 4 filings

Download 13F Summary Create Alert


Top Sells

  • Name% Change


13F Activity

  • Market Value $289.551 Million
  • Prior Market Value $292.327 Million
  • New Purchases2 stocks
  • Additional Purchases0 stocks
  • Sold out of0 stocks
  • Reduced holdings in0 stocks
  • Top 10 Holdings % 94.95 %
  • Turnover % [1]:11.76%
  • Turnover Alt % [2]: %
  • Time Held Top20:9.71 quarters
  • Time Held Top10:6.50 quarters
  • Time Held All:9.71 quarters

[1]: Turnover is calculated by taking the # of new holdings (initial purchases) + the # of positions sold out of (not just reduced) divided by the total # of holdings for the quarter.

[2]: Alt Turnover is calculated by taking either the total MV of new purchases or the MV of securities sold, whichever is less, divided by the total MV of the fund.


13F Sector Allocation Over Time

Portfolio Performance

Top 20 equal-weighted holdings. Performance numbers calculated through 2021-05-17

Performance for Q1 2021: -27.88%
Performance Last 4 Quarters: 156.61%
Performance Metrics
Stdev (5-yrs): Subscription required BETA (5-yrs): Subscription required ALPHA (3-yrs): Subscription required
Max Drawdown (all-years): Subscription required Annualized Perf (3-yrs): Subscription required Batting Avg vs S&P. (3-yrs): Subscription required
Sortino (3-yrs): Subscription required Stutzer (3-yrs): Subscription required Treynor (3-yrs): Subscription required
Sterling (3-yrs): Subscription required Calmar (3-yrs): Subscription required Information Ratio (3-yrs): Subscription required
Tracking Error (3 yrs): Subscription required Stdev Down (3-yrs): Subscription required Winning Months %: Subscription required
Losing Months %: Subscription required Best 12 Months: Subscription required Worst 12 Months: Subscription required
Efficiency Ratio (3-yrs): Subscription required Sharpe: Subscription required Stdev Sectors: Subscription required
Skewness (3-yrs): Subscription required Kurtosis (3-yrs): Subscription required Upside Potential (3-yrs): Subscription required

Refresh Advanced Export Download CSV Download Excel (.xlsx) Download TSV
Filter by:

Security Types:

*Shares are split adjusted

View Last Form Adv Compilation Report on Record


Business Phone: +44 207 534 1500
Fax: +44 207 534 1539
Professional Investment Advisor Data
SEC Registration as :
Form of Organization: Limited Liability Partnership
Organized in:
Number of employees:
Other Business Activities:
Advisor Fees/Compensation:
Amount of client funds and securities:
Total Number of Clients: 0
Amount of client funds and securities by related persons:
Total Number of clients from related persons:
Data above was derived from SEC filings.

Active Schedule 13D and 13G events

Sign in to see

Insider Transactions in the past year


WhaleScore history for ABINGWORTH LLP

You must have a subscription to view WhaleScore histories

**EXPERIMENTAL** Current UK Positions

Updated daily

Contains transactions from January 1st, 2015 on.

Holder Issuer Transaction Date Number of Voting Rights % of Voting Rights
ABINGWORTH LLP Verona Pharma plc 2017-05-03 7,215,553 7.29%
ABINGWORTH LLP Sinclair Pharma plc 2016-09-30 29,674,270 5.91%
ABINGWORTH LLP ReNeuron Group plc 2015-08-25 83,652,000 2.65%

Position History

Holder Issuer Transaction Date Number of Voting Rights % of Voting Rights
ABINGWORTH LLP Verona Pharma plc 2016-07-29 175,527,671 6.84%

Elevate your investments